Barriers and Facilitators to Recurrent Preterm Birth Prevention among Low-Income Women: A Qualitative Study (2024)

Abstract

Objective To examine patient perspectives on the experience of preterm birth (PTB) and recommended PTB prevention strategies, focusing on barriers to and facilitators of PTB prevention among low-income women.

Materials and Methods This is an observational study using qualitative methodology to investigate barriers to and facilitators of recurrent PTB prevention among low-income pregnant and postpartum women. Participants were either (1) postpartum from an initial spontaneous PTB, (2) pregnant and receiving 17-α-hydroxyprogesterone caproate (17P), or (3) pregnant or postpartum and declined/discontinued 17P. Participants completed individual interviews, and transcripts were analyzed using modified grounded theory techniques.

Results Of 33 participants, the majority identified as non-Hispanic black (64%) or Hispanic (27%). Four facilitator themes included patient-centered environment, informed choice, social network, and motivation for a healthy family. Barriers included competing demands, resources, skepticism, and normalization. Three considerations, termed subjective influencers, could support women's decisions to use or decline 17P, including personal beliefs about one's body, the role of the fetus, and beliefs on interventionism.

Conclusion The facilitators and barriers identified herein offer insight into the lived experiences of women at a risk of recurrent PTB. Future programs aimed at reducing PTB disparities may benefit from addressing low-income minority women's structural and social determinants of PTB prevention.

• References

• 1 Committee on Practice Bulletins—Obstetrics, The American College of Obstetricians and Gynecologists Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012; 120 (04) 964-973

  CrossrefPubMedGoogle Scholar

• 2 Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371 (9606): 75-84

  CrossrefPubMedGoogle Scholar

• 3 American College of Obstetricans and Gynecologists Committee Opinion No. 649: Racial and ethnic disparities in obstetrics and gynecology. Obstet Gynecol 2015; 126 (06) e130-e134

  CrossrefPubMedGoogle Scholar

• 4 Eichelberger KY, Doll K, Ekpo GE, Zerden ML. Black lives matter: claiming a space for evidence-based outrage in obstetrics and gynecology. Am J Public Health 2016; 106 (10) 1771-1772

  CrossrefPubMedGoogle Scholar

• 5 Meis PJ, Klebanoff M, Thom E. , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348 (24) 2379-2385

  CrossrefPubMedGoogle Scholar

• 6 Bailit JL, Berkowitz R, Thorp JM, Cleary K, Hartmann KE, Mercer BM. Use of progesterone to prevent preterm birth at a tertiary care center. J Reprod Med 2007; 52 (04) 280-284

  PubMedGoogle Scholar

• 7 Turitz AL, Bastek JA, Purisch SE, Elovitz MA, Levine LD. Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort. Am J Obstet Gynecol 2016; 214 (04) 536.e1-536.e5

  CrossrefPubMedGoogle Scholar

• 8 Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R. Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting. Am J Obstet Gynecol 2007; 197 (03) 262.e1-262.e4

  CrossrefPubMedGoogle Scholar

• 9 Lucas B, Poole-Yaeger A, Istwan N, Stanziano G, Rhea D, Mason M. Pregnancy outcomes of managed Medicaid members prescribed home administration of 17 α-hydroxyprogesterone caproate. Am J Perinatol 2012; 29 (07) 489-496

  Article in Thieme ConnectPubMedGoogle Scholar

• 10 Rebarber A, Ferrara LA, Hanley ML. , et al. Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 2007; 196 (03) 224.e1-224.e4

  CrossrefPubMedGoogle Scholar

• 11 Mason MV, House KM, Linehan J, Speers CA, Joseph LM, Littlejohn R. Optimizing the use of 17P in pregnant managed Medicaid members. Manag Care 2008; 17 (01) 47-52

  PubMedGoogle Scholar

• 12 Yee LM, Liu LY, Sakowicz A, Bolden JR, Miller ES. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth. Am J Obstet Gynecol 2016; 214 (03) 374.e1-374.e6

  CrossrefPubMedGoogle Scholar

• 13 Mazul MC, Salm Ward TC, Ngui EM. Anatomy of good prenatal care: Perspectives of low income African-American women on barriers and facilitators to prenatal care. J Racial Ethn Health Disparities 2017; 4 (01) 79-86

  PubMedGoogle Scholar

• 14 Glaser B, Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago, IL; Aldine Publishing Company: 1967

  Google Scholar

• 15 Strauss A, Corbin J. Basics of Qualitative Research Techniques and Procedures for Developing Grounded Theory. 2nd ed. London:; Sage Publications: 1998

  Google Scholar

• 16 Ulin P, Robinson E, Tolley E. Qualitative Methods in Public Health: A Field Guide for Applied Research. San Francisco, CA: Jossey-Bass; 2005

  Google Scholar

• 17 Clayman ML, Makoul G, Harper MM, Koby DG, Williams AR. Development of a shared decision making coding system for analysis of patient-healthcare provider encounters. Patient Educ Couns 2012; 88 (03) 367-372

  CrossrefPubMedGoogle Scholar

• 18 American College of Obstetricans and Gynecologists. ACOG Committee Opinion No. 736: optimizing postpartum care. Obstet Gynecol 2018; 131 (05) e140-e150

  CrossrefPubMedGoogle Scholar

• 19 McLemore MR, Altman MR, Cooper N, Williams S, Rand L, Franck L. Health care experiences of pregnant, birthing and postnatal women of color at risk for preterm birth. Soc Sci Med 2018; 201: 127-135

  CrossrefPubMedGoogle Scholar

• 20 McKenney KM, Martinez NG, Yee LM. Patient navigation across the spectrum of women's health care in the United States. Am J Obstet Gynecol 2018; 218 (03) 280-286

  CrossrefPubMedGoogle Scholar

• 21 Report to Congress: Patient Navigator Outreach and Chronic Disease Prevention Program, FY 2008–2012. Washington, DC: Department of Health and Human Services Health Resources and Services Administration; 2015

  PubMed

• 22 Rice K, Gressard L, DeGroff A. , et al. Increasing colonoscopy screening in disparate populations: Results from an evaluation of patient navigation in the New Hampshire Colorectal Cancer Screening Program. Cancer 2017; 123 (17) 3356-3366

  CrossrefPubMedGoogle Scholar

• 23 Fischer SM, Cervantes L, Fink RM, Kutner JS. Apoyo con Cariño: a pilot randomized controlled trial of a patient navigator intervention to improve palliative care outcomes for Latinos with serious illness. J Pain Symptom Manage 2015; 49 (04) 657-665

  CrossrefPubMedGoogle Scholar

• 24 Ko NY, Snyder FR, Raich PC. , et al. Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program. Cancer 2016; 122 (17) 2715-2722

  CrossrefPubMedGoogle Scholar

• 25 Wells KJ, Battaglia TA, Dudley DJ. , et al; Patient Navigation Research Program Patient navigation: state of the art or is it science?. Cancer 2008; 113 (08) 1999-2010

  CrossrefPubMedGoogle Scholar

• 26 Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer 2011; 117 (15, Suppl): 3539-3542

  PubMedGoogle Scholar

• 27 Howell EA, Brown H, Brumley J. , et al. Reduction of peripartum racial and ethnic disparities: A conceptual framework and maternal safety consensus bundle. Obstet Gynecol 2018; 131 (05) 770-782

  CrossrefPubMedGoogle Scholar

• 28 Reduction of Peripartum Racial/Ethnic Disparities: Patient Safety Bundle 2018 . Available at: http://safehealthcareforeverywoman.org/patient-safety-bundles/reduction-of-peripartum-racialethnic-disparities/ . Accessed May 15, 2018

  PubMed

• 29 Yee LM, Martinez NG, Nguyen AT, Hajjar N, Chen MJ, Simon MA. Using a patient navigator to improve postpartum care in an urban women's health clinic. Obstet Gynecol 2017; 129 (05) 925-933

  CrossrefPubMedGoogle Scholar